Ichilov Tech, Ichilov hospital's innovation company, curates design partnerships with Israel's
entrepreneurial ecosystem to advance HealthTech innovation. Ichilov Tech streamlines
collaboration between the hospital and the external startup and corporate community and
guides faculty and staff in their advancement of groundbreaking medical solutions for
successful market application
To ensure medical needs are continuously met by cutting-edge science and effective care, Ichilov Tech - Ichilov hospital's innovation company - champions interdisciplinary research, innovation ideation, and industry collaboration.
Responsible for all aspects of innovation management, Ichilov Tech supports hospital scientists and physicians in their advancement of groundbreaking medical solutions for patient health and wellbeing. From idea validation and incubation, through clinical trials and IP licensing, our activities educate and nurture with the aim of positioning discovery for effective market application.
Complementing these efforts, our office streamlines communication and collaboration between the hospital and the external startup and corporate ecosystem. Through an array of activity, we facilitate IP licensing, co-discovery cooperation and internal hospital network, resource, and expertise navigation.
Connect with us to pursue stronger medical need assessment, goal-oriented discovery, and targeted market application.
Ichilov-Tech
Innovation and Tech Transfer Company
Division of Research & Development
Tel-Aviv Sourasky Medical Center
6 Weizmann St. Tel-Aviv 64239, Israel
Through Ichilov Tech, groundbreaking medical solutions are reaching more patients.
Meet the innovators, drivers, and discoveries that are making big things happen.
TECHIES
Yoav’s patients dreaded their multiple-times-a-day trach tube cleaning. So, Yoav invented a smarter solution.
TECHNOVATIONS
Safer grounds for the elderly. procedureProven motor-cognitive technology from Ichilov is on trajectory to market through GaitBetter, a startup that helps reduce fall risk.
TECHOMPANY
Israeli-Canadian biotech company Vaxil is partnering with Ichilov to develop a potential peptide vaccine against COVID-19.
Industry
The Beta Site
with Holistic Value.
We partner with industry's best technological minds, successful entrepreneurs, and visionary
investors to disrupt the continuum of healthcare and jointly create the future of
medicine. Learn how your company can leverage Ichilov’s resources,
facilities, expertise, and clinical data to further our shared mission ensuring medical needs
are consistently met with cutting-edge science and effective care.
Advance your ideas with effective, relevant and knowledgeable strategic counsel and industry access. Our resources and tailored professional teams of external academic and commercial experts will help you develop from proof of concept to prototype while ensuring you are equipped with the understanding of technology transfer, intellectual property, and discovery commercialization.